.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Julphar
Argus Health
Accenture
Baxter
Novartis
Mallinckrodt
AstraZeneca
Covington
Daiichi Sankyo

Generated: February 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: metformin hydrochloride; sitagliptin phosphate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0078-82
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0078-28
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0078-61
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0078-62
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0080-61
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0080-28
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0080-82
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0080-62
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0081-14
Merck Sharp DohmeJANUMET XRmetformin hydrochloride; sitagliptin phosphateTABLET, EXTENDED RELEASE;ORAL202270NDAMerck Sharp & Dohme Corp.N0006-0081-31
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
US Army
Federal Trade Commission
Fuji
McKinsey
Chubb
Merck
Deloitte
US Department of Justice
Healthtrust

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot